Affiliated Pathologists Medical Group, INC.

Affiliated Pathologists Medical Group, INC. was paid $14.14M by Medicaid between Jan 2018 and Dec 2024, across 303 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 14% of everything it billed.

33Billing provider infoAFFILIATED PATHOLOGISTS MEDICAL GROUP, INC.
RANCHO DOMINGUEZ, CA 90220

33aNPI1730119553assigned 07/04/2006

33bProvider typeAnatomic Pathology & Clinical Pathology Physician

28Total paid$14.14M

24GClaims5,969,972

24DCodes billed303

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in California

Rank by total paid#1 of 222

Median peer was paid$42K

This provider vs. median334×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	859,070	$1.74M
2019	848,755	$1.75M
2020	645,052	$1.57M
2021	744,760	$1.81M
2022	664,478	$1.80M
2023	1,137,512	$3.07M
2024incomplete	1,070,345	$2.40M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
88305	Level IV - Surgical pathology, gross and microscopic examination	14%	68,945	56,917	$2.02M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	6.6%	827,385	527,912	$926K
88307		5.4%	13,820	12,273	$770K
80053	Comprehensive metabolic panel	5.4%	485,141	346,379	$762K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	4.9%	52,250	39,912	$689K
88341		4.2%	5,160	4,144	$600K
80048	Basic metabolic panel (calcium, ionized)	3.8%	441,507	243,460	$539K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	3.1%	9,645	9,343	$441K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	3.0%	37,889	35,470	$419K
83880		2.7%	86,223	73,613	$384K
84484		2.4%	218,097	183,767	$343K
88342		2.0%	12,772	10,971	$287K

291 more codes

88304		2.0%	16,524	$276K
83735		1.8%	236,573	$258K
83690		1.8%	240,614	$250K
87040		1.5%	84,053	$212K
80076		1.3%	169,696	$184K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.2%	9,288	$176K
84145		1.1%	41,635	$156K
83605		1.1%	87,034	$153K
84443	Thyroid stimulating hormone (TSH)	1.1%	59,646	$149K
82962		1.0%	46,684	$144K
81001		<1%	272,459	$132K
85027		<1%	129,458	$126K
85610		<1%	215,354	$126K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	11,970	$119K
85730		<1%	124,875	$118K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	22,180	$118K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	22,301	$116K
80074		<1%	18,352	$114K
84702		<1%	56,151	$108K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	9,726	$107K
87086	Culture, bacterial; quantitative colony count, urine	<1%	97,124	$105K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	7,470	$100K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	7,299	$94K
84100		<1%	133,343	$93K
88312		<1%	4,931	$92K
83036	Hemoglobin; glycosylated (A1C)	<1%	55,792	$81K
82948		<1%	71,663	$80K
88313		<1%	2,960	$76K
80061	Lipid panel	<1%	38,994	$75K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	5,623	$65K
87186		<1%	39,232	$59K
82803		<1%	22,936	$55K
87077		<1%	35,032	$54K
80202		<1%	23,517	$50K
82550		<1%	50,518	$49K
85379		<1%	28,855	$43K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	20,752	$41K
87070		<1%	29,399	$38K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	7,568	$38K
87641		<1%	6,654	$37K
88189		<1%	838	$37K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	2,007	$37K
86901		<1%	84,590	$35K
84703		<1%	37,081	$35K
87081		<1%	36,791	$35K
81003		<1%	98,919	$35K
86900		<1%	75,186	$35K
87150		<1%	578	$32K
82140		<1%	14,410	$32K
88112		<1%	1,606	$30K
82330		<1%	13,478	$30K
82947		<1%	30,081	$30K
86140		<1%	37,781	$30K
87631		<1%	2,851	$29K
86850		<1%	53,122	$29K
84439		<1%	20,636	$28K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	7,954	$27K
81025		<1%	27,281	$26K
82728		<1%	12,963	$26K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,234	$23K
85060		<1%	2,618	$23K
86920		<1%	7,139	$22K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,577	$21K
82553		<1%	11,361	$21K
82746		<1%	9,309	$20K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	784	$20K
84155		<1%	50,984	$20K
87428		<1%	1,021	$19K
87634		<1%	2,513	$19K
86077		<1%	765	$19K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	5,493	$18K
82533		<1%	6,922	$16K
86780		<1%	9,737	$16K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	2,621	$15K
87205		<1%	22,246	$15K
80329		<1%	13,052	$15K
87088		<1%	12,778	$14K
86880		<1%	15,471	$13K
88300		<1%	3,182	$13K
83540		<1%	13,053	$13K
88108		<1%	1,222	$13K
82607		<1%	6,074	$13K
80055		<1%	1,460	$13K
88311		<1%	3,711	$12K
83615		<1%	16,371	$12K
85007		<1%	25,302	$12K
80320		<1%	16,007	$12K
87149		<1%	555	$12K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	10,087	$12K
87075		<1%	7,037	$11K
84481		<1%	4,553	$11K
88360		<1%	249	$10K
83498		<1%	2,379	$10K
82570		<1%	11,183	$10K
83550		<1%	8,109	$9K
S3620	Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)	<1%	786	$9K
87210		<1%	12,567	$9K
86141		<1%	3,943	$8K
87340		<1%	5,684	$8K
87400		<1%	8,267	$8K
86592		<1%	11,542	$8K
84466		<1%	3,583	$7K
83021		<1%	2,574	$7K
82010		<1%	4,683	$7K
83789		<1%	2,381	$7K
84550		<1%	10,893	$7K
89051		<1%	1,887	$7K
81479	Unlisted molecular pathology procedure	<1%	714	$6K
82247		<1%	7,977	$6K
82261		<1%	2,380	$6K
82150		<1%	5,886	$6K
85018		<1%	15,253	$5K
83970		<1%	794	$5K
82805		<1%	921	$5K
83516		<1%	3,071	$5K
86803		<1%	2,145	$5K
85014		<1%	13,896	$5K
84112		<1%	303	$5K
85652		<1%	12,007	$5K
84425		<1%	1,330	$5K
86038		<1%	1,819	$5K
87522	Neg quan hep c or qual rna	<1%	657	$5K
80069		<1%	4,188	$5K
85384		<1%	3,366	$5K
87486		<1%	654	$4K
87581		<1%	654	$4K
86923		<1%	551	$4K
88302		<1%	264	$4K
84156		<1%	7,072	$4K
86906		<1%	6,507	$4K
87493		<1%	771	$4K
87807		<1%	3,472	$4K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	292	$4K
82248		<1%	6,142	$3K
84132		<1%	8,627	$3K
86480		<1%	295	$3K
82776		<1%	2,377	$3K
80047		<1%	3,149	$3K
86762		<1%	1,233	$3K
87147		<1%	3,076	$3K
88141		<1%	263	$3K
80143		<1%	1,254	$3K
85651		<1%	6,013	$3K
86481		<1%	224	$3K
80179		<1%	1,303	$3K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	384	$3K
86703		<1%	1,381	$3K
82378		<1%	942	$3K
86022		<1%	889	$2K
84403		<1%	471	$2K
84300		<1%	2,719	$2K
86922		<1%	782	$2K
84153		<1%	683	$2K
84295		<1%	4,461	$2K
86870		<1%	518	$2K
85380		<1%	2,368	$2K
88104		<1%	166	$2K
87430		<1%	2,025	$2K
85520		<1%	230	$2K
83930		<1%	1,699	$2K
82565		<1%	3,246	$2K
87640		<1%	270	$2K
84134		<1%	670	$2K
87015		<1%	1,306	$2K
86300		<1%	446	$1K
84478		<1%	2,434	$1K
80164		<1%	628	$1K
82435		<1%	4,306	$1K
87116		<1%	665	$1K
81002		<1%	4,169	$1K
82043		<1%	1,344	$1K
87420		<1%	2,703	$1K
80185		<1%	723	$1K
85378		<1%	1,196	$1K
87507		<1%	12	$1K
87102		<1%	664	$1K
82950		<1%	1,224	$986.34
82040		<1%	1,048	$941.43
80192		<1%	334	$920.05
86003		<1%	44	$894.62
82042		<1%	1,715	$882.91
86701		<1%	781	$874.76
82270		<1%	1,642	$835.38
82784		<1%	441	$831.74
86403		<1%	444	$806.65
87808		<1%	541	$782.16
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	83	$761.00
87045		<1%	513	$751.80
87660		<1%	210	$721.89
87449		<1%	465	$609.47
85044		<1%	1,426	$601.30
87206		<1%	594	$598.00
85055		<1%	217	$597.27
85045		<1%	885	$592.36
83986		<1%	1,259	$589.63
85046		<1%	651	$573.92
87480		<1%	166	$569.47
87510		<1%	166	$569.47
88374		<1%	18	$555.17
82465		<1%	984	$546.28
82977		<1%	1,105	$539.94
84520		<1%	1,273	$507.19
84436		<1%	581	$504.73
82009		<1%	753	$499.21
86706		<1%	392	$469.07
82670		<1%	97	$468.81
89060		<1%	95	$465.92
84270		<1%	121	$460.02
84030		<1%	464	$457.66
82310		<1%	1,217	$453.01
82731		<1%	40	$441.49
83520		<1%	145	$427.62
87899		<1%	285	$424.43
83935		<1%	375	$421.93
86317		<1%	160	$410.15
84157		<1%	767	$405.05
86021		<1%	203	$404.13
82785		<1%	123	$403.85
83655		<1%	191	$389.29
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	78	$381.09
86200		<1%	273	$374.76
85362		<1%	366	$357.82
86039		<1%	171	$343.02
87209		<1%	89	$295.93
87073		<1%	294	$287.07
86308		<1%	381	$282.40
87490		<1%	128	$279.07
82375		<1%	168	$275.40
85049		<1%	359	$263.69
82747		<1%	157	$257.70
87338		<1%	111	$253.87
84480		<1%	96	$240.92
86618		<1%	69	$226.17
84075		<1%	464	$222.11
84165		<1%	113	$205.58
86430		<1%	200	$197.53
86376		<1%	74	$176.06
82945		<1%	288	$175.10
84460		<1%	543	$174.58
87046		<1%	213	$172.21
84450		<1%	548	$153.15
83050		<1%	161	$152.70
83883		<1%	44	$147.60
87177		<1%	89	$146.89
87324		<1%	106	$115.42
86902		<1%	43	$112.01
87299		<1%	62	$111.20
82374		<1%	860	$109.25
82272		<1%	89	$105.08
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	13	$100.88
86225		<1%	54	$96.24
82627		<1%	24	$94.08
87481		<1%	15	$83.82
83525		<1%	43	$82.89
84133		<1%	113	$81.02
83001		<1%	29	$78.72
81005		<1%	141	$76.70
83921		<1%	26	$76.44
86800		<1%	31	$76.14
82436		<1%	88	$71.76
80178		<1%	60	$71.07
87427		<1%	38	$65.39
86160		<1%	15	$54.60
85347		<1%	30	$50.84
82365		<1%	35	$45.98
80170		<1%	18	$45.51
36415	Collection of venous blood by venipuncture	<1%	21	$43.57
82232		<1%	14	$42.90
84540		<1%	68	$42.77
83721		<1%	26	$42.64
82610		<1%	14	$41.44
80306		<1%	111	$41.13
84144		<1%	12	$40.26
86704		<1%	37	$40.14
86431		<1%	55	$37.99
83010		<1%	15	$33.00
86708		<1%	12	$32.41
86694		<1%	15	$31.20
87181		<1%	135	$25.79
84630		<1%	14	$25.48
86705		<1%	13	$24.84
87101		<1%	16	$23.18
81000		<1%	31	$18.42
87254		<1%	13	$18.21
84160		<1%	16	$16.32
87276		<1%	13	$15.47
87275		<1%	13	$15.47
86593		<1%	27	$10.03
87185		<1%	15	$2.60
80354		0%	32	$0.00
86999		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKENNEBREW, STANETTE (ADMINISTRATOR)